Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Research Article
  • Published:

Linkage of the dopamine receptor D1 gene to attention-deficit/hyperactivity disorder

Molecular Psychiatry volume 9, pages 500–509 (2004)Cite this article

Abstract

Attention-deficit/hyperactivity disorder (ADHD) has a strong genetic basis, and evidence from human and animal studies suggests the dopamine receptor D1 gene, DRD1, to be a good candidate for involvement. Here, we tested for linkage of DRD1 to ADHD by examining the inheritance of four biallelic DRD1 polymorphisms [D1P.5 (–1251HaeIII), D1P.6 (−800HaeIII), D1.1 (−48DdeI) and D1.7 (+1403Bsp1286I)] in a sample of 156 ADHD families. Owing to linkage disequilibrium between alleles at the four markers, only three haplotypes are common in our sample. Using the transmission/disequilibrium test (TDT), we observed a strong bias for transmission of Haplotype 3 (1.1.1.2) from heterozygous parents to their affected children (P=0.008). Furthermore, using quantitative trait TDT analyses, we found significant and positive relationships between Haplotype 3 transmission and the inattentive symptoms, but not the hyperactive/impulsive symptoms, of ADHD. These findings support the proposed involvement of DRD1 in ADHD, and implicate Haplotype 3, in particular, as containing a potential risk factor for the inattentive symptom dimension of the disorder. Since none of the four marker alleles comprising Haplotype 3 is predicted to alter DRD1 function, we hypothesize that a functional DRD1 variant, conferring susceptibility to ADHD, is on this haplotype. To search for such a variant we screened the DRD1 coding region, by sequencing, focusing on the children who showed preferential transmission of Haplotype 3. DNA from 41 children was analysed, and no sequence variations were identified, indicating that the putative DRD1 risk variant for ADHD resides outside of the coding region of the gene.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Thapar A, Holmes J, Poulton K, Harrington R . Genetic basis of attention deficit and hyperactivity. Br J Psychiatry 1999; 174: 105–111.

    Article  CAS  PubMed  Google Scholar 

  2. Faraone SV, Biederman J . Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry 1998; 44: 951–958.

    Article  CAS  PubMed  Google Scholar 

  3. Barr CL, Swanson JM, Kennedy JL . Molecular genetics of ADHD. In: Levy F, Hay D (eds) Attention, Genes and ADHD. Taylor and Francis Inc.: Philadelphia, PA, 2001, pp 173–195.

    Google Scholar 

  4. Gillis JJ, Gilger JW, Pennington BF, DeFries JC . Attention deficit disorder in reading-disabled twins: evidence for a genetic etiology. J Abnormal Child Psychol 1992; 20: 303–315.

    Article  CAS  Google Scholar 

  5. Thapar A, Hervas A, McGuffin P . Childhood hyperactivity scores are highly heritable and show sibling competition effects: twin study evidence. Behav Genet 1995; 25: 537–544.

    Article  CAS  PubMed  Google Scholar 

  6. Gjone H, Stevenson J, Sundet JM . Genetic influence on parent-reported attention-related problems in a Norwegian general population twin sample. J Am Acad Child Adolesc Psychiatry 1996; 35: 588–596.

    Article  CAS  PubMed  Google Scholar 

  7. Levy F, Hay DA, McStephen M, Wood C, Waldman I . Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry 1997; 36: 737–744.

    Article  CAS  PubMed  Google Scholar 

  8. Sherman DK, Iacono WG, McGue MK . Attention-deficit hyperactivity disorder dimensions: a twin study of inattention and impulsivity–hyperactivity. J Am Acad Child Adolesc Psychiatry 1997; 36: 745–753.

    Article  CAS  PubMed  Google Scholar 

  9. Seeman P, Madras BK . Anti-hyperactivity medication: methylphenidate and amphetamine. Mol Psychiatry 1998; 3: 386–396.

    Article  CAS  PubMed  Google Scholar 

  10. Levy F . The dopamine theory of attention deficit hyperactivity disorder (ADHD). Aust NZ J Psychiatry 1991; 25: 277–283.

    Article  CAS  Google Scholar 

  11. Faraone SV, Doyle AE, Mick E, Biederman J . Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry 2001; 158: 1052–1057.

    Article  CAS  PubMed  Google Scholar 

  12. Maher BS, Marazita ML, Ferrell RE, Vanyukov MM . Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis. Psychiatr Genet 2002; 12: 207–215.

    Article  PubMed  Google Scholar 

  13. Wang HY, Undie AS, Friedman E . Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation. Mol Pharmacol 1995; 48: 988–994.

    CAS  PubMed  Google Scholar 

  14. Jin LQ, Wang HY, Friedman E . Stimulated D(1) dopamine receptors couple to multiple Galpha proteins in different brain regions. J Neurochem 2001; 78: 981–990.

    Article  CAS  PubMed  Google Scholar 

  15. Jackson DM, Westlind-Danielsson A . Dopamine receptors: molecular biology, biochemistry and behavioural aspects. Pharmacol Ther 1994; 64: 291–370.

    Article  CAS  PubMed  Google Scholar 

  16. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG . Dopamine receptors: from structure to function. Physiol Rev 1998; 78: 189–225.

    Article  CAS  PubMed  Google Scholar 

  17. Arnsten AF, Steere JC, Hunt RD . The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1996; 53: 448–455.

    Article  CAS  PubMed  Google Scholar 

  18. Arnsten AFT . Dopaminergic and noradrenergic influences on cognitive functions mediated by prefrontal cortex. In: Solanto MV, Arnsten AFT, Castellanos FX (eds). Stimulant Drugs and ADHD. Basic and Clinical Neuroscience. Oxford University Press, Inc.: New York, NY, 2001, pp 185–208.

    Google Scholar 

  19. Denney CB, Rapport MD . Cognitive pharmacology of stimulants in children with ADHD. In: Solanto MV, Arnsten AFT, Castellanos FX (eds) Stimulant Drugs and ADHD. Basic and Clinical Neuroscience. Oxford University Press, Inc.: New York, NY, 2001, pp 283–302.

    Google Scholar 

  20. Castellanos FX . Neuroimaging studies of ADHD. In: Solanto MV, Arnsten AFT, Castellanos FX (eds). Stimulant Drugs and ADHD. Basic and Clinical Neuroscience. Oxford University Press, Inc.: New York, NY, 2001, pp 243–258.

    Google Scholar 

  21. Sawaguchi T, Goldman-Rakic PS . D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 1991; 251: 947–950.

    Article  CAS  PubMed  Google Scholar 

  22. Williams GV, Goldman-Rakic PS . Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 1995; 376: 572–575.

    Article  CAS  PubMed  Google Scholar 

  23. Castellanos FX, Tannock R . Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci 2002; 3: 617–628.

    Article  CAS  PubMed  Google Scholar 

  24. de Fockert JW, Rees G, Frith CD, Lavie N . The role of working memory in visual selective attention. Science 2001; 291: 1803–1806.

    Article  CAS  PubMed  Google Scholar 

  25. Conway AR, Cowan N, Bunting MF . The cocktail party phenomenon revisited: the importance of working memory capacity. Psychon Bull Rev 2001; 8: 331–335.

    Article  CAS  PubMed  Google Scholar 

  26. Clifford JJ, Tighe O, Croke DT, Sibley DR, Drago J, Waddington JL . Topographical evaluation of the phenotype of spontaneous behaviour in mice with targeted gene deletion of the D1A dopamine receptor: paradoxical elevation of grooming syntax. Neuropharmacology 1998; 37: 1595–1602.

    Article  CAS  PubMed  Google Scholar 

  27. Xu M, Hu XT, Cooper DC, Moratalla R, Graybiel AM, White FJ et al. Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell 1994; 79: 945–955.

    Article  CAS  PubMed  Google Scholar 

  28. Xu M, Moratalla R, Gold LH, Hiroi N, Koob GF, Graybiel AM et al. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 1994; 79: 729–742.

    Article  CAS  PubMed  Google Scholar 

  29. Karasinska JM, George SR, El-Ghundi M, Fletcher PJ, O'Dowd BF . Modification of dopamine D(1) receptor knockout phenotype in mice lacking both dopamine D(1) and D(3) receptors. Eur J Pharmacol 2000; 399: 171–181.

    Article  CAS  PubMed  Google Scholar 

  30. Drago J, Gerfen CR, Lachowicz JE, Steiner H, Hollon TR, Love PE et al. Altered striatal function in a mutant mouse lacking D1A dopamine receptors. Proc Natl Acad Sci USA 1994; 91: 12564–12568.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Smith DR, Striplin CD, Geller AM, Mailman RB, Drago J, Lawler CP et al. Behavioural assessment of mice lacking D1A dopamine receptors. Neuroscience 1998; 86: 135–146.

    Article  CAS  PubMed  Google Scholar 

  32. Cromwell HC, Berridge KC, Drago J, Levine MS . Action sequencing is impaired in D1A-deficient mutant mice. Eur J Neurosci 1998; 10: 2426–2432.

    Article  CAS  PubMed  Google Scholar 

  33. Kadesjo B, Gillberg C . Attention deficits and clumsiness in Swedish 7-year-old children. Dev Med Child Neurol 1998; 40: 796–804.

    Article  CAS  PubMed  Google Scholar 

  34. Barkley RA . Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 1997; 121: 65–94.

    Article  PubMed  Google Scholar 

  35. Sagvolden T . Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci Biobehav Rev 2000; 24: 31–39.

    Article  CAS  PubMed  Google Scholar 

  36. Russell VA . Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder—the spontaneously hypertensive rat. Behav Brain Res 2002; 130: 191–196.

    Article  CAS  PubMed  Google Scholar 

  37. Sadile AG . Multiple evidence of a segmental defect in the anterior forebrain of an animal model of hyperactivity and attention deficit. Neurosci Biobehav Rev 2000; 24: 161–169.

    Article  CAS  PubMed  Google Scholar 

  38. Amenta F, Ricci A, Rossodivita I, Avola R, Tayebati SK . The dopaminergic system in hypertension. Clin Exp Hypertens 2001; 23: 15–24.

    Article  CAS  PubMed  Google Scholar 

  39. Hussain T, Kansra V, Lokhandwala MF . Renal dopamine receptor signaling mechanisms in spontaneously hypertensive and Fischer 344 day old rats. Clin Exp Hypertens 1999; 21: 25–36.

    Article  CAS  PubMed  Google Scholar 

  40. Sagvolden T, Hendley ED, Knardahl S . Behavior of hypertensive and hyperactive rat strains: hyperactivity is not unitarily determined. Physiol Behav 1992; 52: 49–57.

    Article  CAS  PubMed  Google Scholar 

  41. Viggiano D, Vallone D, Welzl H, Sadile AG . The Naples High- and Low-Excitability rats: selective breeding, behavioral profile, morphometry, and molecular biology of the mesocortical dopamine system. Behav Genet 2002; 32: 315–333.

    Article  PubMed  Google Scholar 

  42. Barr CL, Wigg K, Malone M, Schachar R, Tannock R, Roberts W et al. Linkage study of catechol-O-methyltransferase and attention-deficit hyperactivity disorder. Am J Med Genet 1999; 88: 710–713.

    Article  CAS  PubMed  Google Scholar 

  43. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders–Fourth Edition. American Psychiatric Association: Washington, DC, 1994.

  44. Wechsler DI . Examiner's Manual: Wechsler Intelligence Scale for Children—Third Edition. Psychological Corporation: New York, NY, 1991.

    Google Scholar 

  45. Ickowicz A, Schachar R, Sugarman R, Chen S, Millette C, Cook L et al. Reliability and validity of the Parent Interview for Child Symptoms (PICS), Paper Presented at 49th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, 2002##San Francisco, CA.

    Google Scholar 

  46. Tannock R, Hum M, Masellis M, Humphries T, Schachar R . Teacher Telephone Interview for Children's Academic Performance, Attention, Behaviour and Learning: DSM-IV Version (TTI-IV). The Hospital for Sick Children: Toronto, Canada, Unpublished document, 2002.

  47. Conners CK . Conners' Rating Scales—Revised. Multi-Health Systems: Toronto, Canada, 1997.

    Google Scholar 

  48. Boyle MH, Offord DR, Racine Y, Fleming JE, Szatmari P, Sanford M . Evaluation of the revised Ontario Child Health Study scales. J Child Psychol Psychiatry 1993; 34: 189–213.

    Article  CAS  PubMed  Google Scholar 

  49. Wilkinson GS . Wide Range Achievement Test 3—Revision 3. Jastak Associates: Wilmington, DE, 1993.

    Google Scholar 

  50. Semel E, Wing E, Secord W . Clinical Evaluation of Language Fundamentals—Third Edition (CELF-3). The Psychological Corporation: San Antonio, TX, 1995.

    Google Scholar 

  51. Kovacs M . Manual: The Children's Depression Inventory. Multi-Health Systems: Toronto, Canada, 1995.

    Google Scholar 

  52. Reynolds CR, Richmond BO . What I Think and Feel (RCMAS). Western Psychological Services: Los Angeles, CA, 1985.

    Google Scholar 

  53. Miller SA, Dykes DD, Polesky HF . A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Cichon S, Nothen MM, Erdmann J, Propping P . Detection of four polymorphic sites in the human dopamine D1 receptor gene (DRD1). Hum Mol Genet 1994; 3: 209.

    Article  CAS  PubMed  Google Scholar 

  55. Cichon S, Nothen MM, Stober G, Schroers R, Albus M, Maier W et al. Systematic screening for mutations in the 5′-regulatory region of the human dopamine D1 receptor (DRD1) gene in patients with schizophrenia and bipolar affective disorder. Am J Med Genet 1996; 67: 424–428.

    Article  CAS  PubMed  Google Scholar 

  56. Devlin B, Risch N . A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 1995; 29: 311–322.

    Article  CAS  PubMed  Google Scholar 

  57. Lewontin RC . The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 1964; 49: 49–67.

    CAS  PubMed  PubMed Central  Google Scholar 

  58. Ott J . Analysis of Human Genetic Linkage. The Johns Hopkins University Press: Baltimore, MD, 1991.

    Google Scholar 

  59. Sham PC, Curtis D . An extended transmission/disequilibrium test (TDT) for multi-allele marker loci. Ann Hum Genet 1995; 59: 323–336.

    Article  CAS  PubMed  Google Scholar 

  60. Clayton D . A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. Am J Hum Genet 1999; 65: 1170–1177.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Curtis D, Sham PC . A note on the application of the transmission disequilibrium test when a parent is missing. Am J Hum Genet 1995; 56: 811–812.

    CAS  PubMed  PubMed Central  Google Scholar 

  62. Cervino AC, Hill AV . Comparison of tests for association and linkage in incomplete families. Am J Hum Genet 2000; 67: 120–132.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Laird NM, Horvath S, Xu X . Implementing a unified approach to family-based tests of association. Genet Epidemiol 2000; 19: S36–S42.

    Article  PubMed  Google Scholar 

  64. The FBAT Program v1.4.1##http://www.biostat.harvard.edu/~fbat/default.html.

  65. Waldman ID, Robinson BF, Rowe DC . A logistic regression based extension of the TDT for continuous and categorical traits. Ann Hum Genet 1999; 63: 329–340.

    Article  CAS  PubMed  Google Scholar 

  66. Spielman RS, Ewens WJ . The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet 1996; 59: 983–989.

    CAS  PubMed  PubMed Central  Google Scholar 

  67. Spielman RS, McGinnis RE, Ewens WJ . Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506–516.

    CAS  PubMed  PubMed Central  Google Scholar 

  68. Ewens WJ, Spielman RS . The transmission/disequilibrium test: history, subdivision, and admixture. Am J Hum Genet 1995; 57: 455–464.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Ewens WJ, Spielman RS . The transmission/disequilibrium test. In: Balding DJ (ed). Handbook of Statistical Genetics. John Wiley & Sons, Ltd.: New York, 2001, pp 507–518.

    Google Scholar 

  70. Wong AH, Buckle CE, Van Tol HH . Polymorphisms in dopamine receptors: what do they tell us? Eur J Pharmacol 2000; 410: 183–203.

    Article  CAS  PubMed  Google Scholar 

  71. Minowa MT, Minowa T, Mouradian MM . Activator region analysis of the human D1A dopamine receptor gene. J Biol Chem 1993; 268: 23544–23551.

    CAS  PubMed  Google Scholar 

  72. Lee SH, Mouradian MM . Up-regulation of D1A dopamine receptor gene transcription by estrogen. Mol Cell Endocrinol 1999; 156: 151–157.

    Article  PubMed  Google Scholar 

  73. Neuman RJ, Todd RD, Heath AC, Reich W, Hudziak JJ, Bucholz KK et al. Evaluation of ADHD typology in three contrasting samples: a latent class approach. J Am Acad Child Adolesc Psychiatry 1999; 38: 25–33.

    Article  CAS  PubMed  Google Scholar 

  74. Stevenson J . Evidence for a genetic etiology in hyperactivity in children. Behav Genet 1992; 22: 337–344.

    Article  CAS  PubMed  Google Scholar 

  75. Goodman R, Stevenson J . A twin study of hyperactivity—II. The aetiological role of genes, family relationships and perinatal adversity. J Child Psychol Psychiatry 1989; 30: 691–709.

    Article  CAS  PubMed  Google Scholar 

  76. Kirley A, Hawi Z, Daly G, McCarron M, Mullins C, Millar N et al. Dopaminergic system genes in ADHD: toward a biological hypothesis. Neuropsychopharmacology 2002; 27: 607–619.

    CAS  PubMed  Google Scholar 

  77. Daly G, Hawi Z, Fitzgerald M, Gill M . Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry 1999; 4: 192–196.

    Article  CAS  PubMed  Google Scholar 

  78. Lahey BB, Applegate B, McBurnett K, Biederman J, Greenhill L, Hynd GW et al. DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry 1994; 151: 1673–1685.

    Article  CAS  PubMed  Google Scholar 

  79. Wolraich ML, Hannah JN, Pinnock TY, Baumgaertel A, Brown J . Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry 1996; 35: 319–324.

    Article  CAS  PubMed  Google Scholar 

  80. Feng J, Sobell JL, Heston LL, Cook Jr EH, Goldman D, Sommer SS . Scanning of the dopamine D1 and D5 receptor genes by REF in neuropsychiatric patients reveals a novel missense change at a highly conserved amino acid. Am J Med Genet 1998; 81: 172–178.

    Article  CAS  PubMed  Google Scholar 

  81. Thompson M, Comings DE, Feder L, George SR, O'Dowd BF . Mutation screening of the dopamine D1 receptor gene in Tourette's syndrome and alcohol dependent patients. Am J Med Genet 1998; 81: 241–244.

    Article  CAS  PubMed  Google Scholar 

  82. Fisher SE, Francks C, McCracken JT, McGough JJ, Marlow AJ, MacPhie IL et al. A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. Am J Hum Genet 2002; 70: 1183–1196.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Lidow MS, Roberts A, Zhang L, Koh PO, Lezcano N, Bergson C . Receptor crosstalk protein, calcyon, regulates affinity state of dopamine D1 receptors. Eur J Pharmacol 2001; 427: 187–193.

    Article  CAS  PubMed  Google Scholar 

  84. Lezcano N, Mrzljak L, Eubanks S, Levenson R, Goldman-Rakic P, Bergson C . Dual signaling regulated by calcyon, a D1 dopamine receptor interacting protein. Science 2000; 287: 1660–1664.

    Article  CAS  PubMed  Google Scholar 

  85. Minowa MT, Minowa T, Monsma Jr FJ, Sibley DR, Mouradian MM . Characterization of the 5′ flanking region of the human D1A dopamine receptor gene. Proc Natl Acad Sci USA 1992; 89: 3045–3049.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Lee SH, Minowa MT, Mouradian MM . Two distinct promoters drive transcription of the human D1A dopamine receptor gene. J Biol Chem 1996; 271: 25292–25299.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from The Hospital for Sick Children Research Training Committee (VLM), The Hospital for Sick Children Psychiatric Endowment Fund (CLB), and the Canadian Institutes of Health Research MT14336 and MOP14334 (CLB).

Author information

Authors and Affiliations

  1. Cell and Molecular Biology Division, Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada

    V L Misener, P Luca, O Azeke & C L Barr

  2. Department of Psychiatry, The Hospital for Sick Children, Toronto, Ontario, Canada

    J Crosbie, R Tannock, R Schachar, A Ickowicz & C L Barr

  3. Department of Psychology, Emory University, Atlanta, GA, USA

    I Waldman

  4. Brain and Behaviour Program, The Hospital for Sick Children, Toronto, Ontario, Canada

    R Tannock, R Schachar & C L Barr

  5. Division of Neurology, The Hospital for Sick Children, Toronto, Ontario, Canada

    W Roberts & M Malone

  6. Department of Psychiatry, Neurogenetics Section, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada

    J L Kennedy

Authors
  1. V L Misener
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P Luca
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. O Azeke
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J Crosbie
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I Waldman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R Tannock
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. W Roberts
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M Malone
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. R Schachar
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. A Ickowicz
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. J L Kennedy
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. C L Barr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C L Barr.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Misener, V., Luca, P., Azeke, O. et al. Linkage of the dopamine receptor D1 gene to attention-deficit/hyperactivity disorder. Mol Psychiatry 9, 500–509 (2004). https://doi.org/10.1038/sj.mp.4001440

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4001440

Keywords

This article is cited by

Search

Advanced search

Quick links